ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 184 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $430,000 | -36.4% | 461,500 | +39.3% | 0.00% | -33.3% |
| Q4 2019 | $676,000 | -25.1% | 331,400 | +5.3% | 0.00% | +50.0% |
| Q3 2019 | $902,000 | +37.7% | 314,600 | +268.0% | 0.00% | -33.3% |
| Q2 2019 | $655,000 | -3.1% | 85,500 | +68.0% | 0.00% | 0.0% |
| Q1 2019 | $676,000 | +3.2% | 50,900 | +20.9% | 0.00% | 0.0% |
| Q4 2018 | $655,000 | -23.5% | 42,100 | -3.4% | 0.00% | -25.0% |
| Q3 2018 | $856,000 | -13.5% | 43,600 | +26.4% | 0.00% | 0.0% |
| Q2 2018 | $990,000 | +14.5% | 34,500 | -5.7% | 0.00% | 0.0% |
| Q1 2018 | $865,000 | -2.3% | 36,600 | -11.4% | 0.00% | 0.0% |
| Q4 2017 | $885,000 | +0.9% | 41,300 | +11.3% | 0.00% | 0.0% |
| Q3 2017 | $877,000 | +4.8% | 37,100 | -12.7% | 0.00% | 0.0% |
| Q2 2017 | $837,000 | +17.7% | 42,500 | +25.4% | 0.00% | +33.3% |
| Q1 2017 | $711,000 | -76.9% | 33,900 | -79.3% | 0.00% | -78.6% |
| Q4 2016 | $3,075,000 | -10.0% | 163,600 | 0.0% | 0.01% | -6.7% |
| Q3 2016 | $3,415,000 | -14.2% | 163,600 | +4.8% | 0.02% | -16.7% |
| Q2 2016 | $3,981,000 | +26.2% | 156,100 | +30.8% | 0.02% | +38.5% |
| Q1 2016 | $3,155,000 | -34.9% | 119,300 | +5.3% | 0.01% | -40.9% |
| Q4 2015 | $4,846,000 | +11.7% | 113,300 | -30.7% | 0.02% | +4.8% |
| Q3 2015 | $4,337,000 | -14.0% | 163,600 | +8.1% | 0.02% | -4.5% |
| Q2 2015 | $5,042,000 | +14.9% | 151,300 | +14.7% | 0.02% | +15.8% |
| Q1 2015 | $4,389,000 | -17.1% | 131,900 | +1.9% | 0.02% | -17.4% |
| Q4 2014 | $5,293,000 | -48.0% | 129,500 | -56.9% | 0.02% | -4.2% |
| Q3 2014 | $10,178,000 | +90.4% | 300,400 | +89.4% | 0.02% | 0.0% |
| Q2 2014 | $5,346,000 | +362.5% | 158,600 | +420.0% | 0.02% | +380.0% |
| Q1 2014 | $1,156,000 | +9.1% | 30,500 | -16.0% | 0.01% | 0.0% |
| Q4 2013 | $1,060,000 | -19.7% | 36,300 | -5.7% | 0.01% | -16.7% |
| Q3 2013 | $1,320,000 | +3.9% | 38,500 | 0.0% | 0.01% | +20.0% |
| Q2 2013 | $1,270,000 | – | 38,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |